title: European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality?
authors.affiliation: Human Neurotransmitters/Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
authors.forename: Nora
authors.initials: N
authors.lastname: Straznicky
authors.forename: Guido
authors.initials: G
authors.lastname: Grassi
authors.forename: Murray
authors.initials: M
authors.lastname: Esler
authors.forename: Gavin
authors.initials: G
authors.lastname: Lambert
authors.forename: John
authors.initials: J
authors.lastname: Dixon
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Lambert
authors.forename: Jens
authors.initials: J
authors.lastname: Jordan
authors.forename: Markus
authors.initials: M
authors.lastname: Schlaich
mesh_terms: D000328:Adult; D019440:Anti-Obesity Agents / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D004039:Diet, Sodium-Restricted; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009765:Obesity / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D040242:Risk Reduction Behavior; D015431:Weight Loss
chemical_list: D019440:Anti-Obesity Agents; D000959:Antihypertensive Agents